Diligentia President, Joff Masukawa, will serve as a panelist at the Virginia Bioscience Commerciali
Joff Masukawa, Diligentia Strategy, will be the featured speaker at the November 3rd Virginia Bioscience Commercialization Luncheon. He will address commercialization strategies for biopharmaceuticals with a focus on the marketplace for rare diseases, orphan drugs, and specialty pharmaceuticals.
If you are attending the luncheon and would like to learn about how Diligentia can support your commercial business objectives, email us at email@example.com.
Click here to register and for more information on the event.